Actively Recruiting
Bergamo Lymphoid Cancer Registry
Led by A.O. Ospedale Papa Giovanni XXIII · Updated on 2024-03-06
6000
Participants Needed
1
Research Sites
1043 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This registry has been established to gain a better understanding of the clinical and biological characteristics and outcome of patients with lymphoid cancer
CONDITIONS
Official Title
Bergamo Lymphoid Cancer Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patients 18 years or older
- Written informed consent
- Confirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
You will not qualify if you...
- Unconfirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa Giovanni XXIII
Bergamo, Italy, 24127
Actively Recruiting
Research Team
A
Alessandro Rambaldi, MD
CONTACT
G
Giuseppe Gritti, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here